company? Let’s change
that.
OUR MISSION: Empower Discovery. Enable Innovation. Improve Life. For over 25 years, Mirus Bio has pioneered the development of transfection reagents and proprietary technologies for nucleic acid delivery applications. Our work is both technical and cutting-edge, and we promote a culture of creativity, responsibility, and respect. Our team members are engaged and motivated by the desire to support our customers and partners to achieve strong results. Mirus, together with Gamma Biosciences, is establishing the future of science and medicine by developing products that enable product developers within the cell and gene therapy space. As we approach a new era of addressing and conquering life-altering diseases, we will continue to expand our expertise and leadership in transfection to be integral in the future of advanced therapies. Mirus Bio is a Gamma Biosciences Company.
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Exact Sciences is changing the way we think about detecting and treating cancer. As a leader in cancer testing, we are committed to providing earlier answers and life-changing treatment guidance.
At Accuray, we make a direct and powerful impact on the lives of cancer patients every day — helping them live longer, better lives. But our commitment to innovation offers a truly unique opportunity: the chance to change the fight against cancer — helping to develop, introduce and support new treatment delivery systems and software that will give new hope and new health to cancer patients and cancer survivors around the world. Accuray develops, manufactures and sells radiotherapy systems for alternative cancer treatments. Our radiation therapy for cancer makes treatment shorter, safer, personalized and more effective, ultimately enabling patients to live longer, better lives.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
CLG -Multi-species Stem Cell Characterization Services and Products & Custom Assay Development
Centrose is a biotechnology company engaged in the development and commercialization of therapeutics targeting disease related cells.
Capio Biosciences focuses on delivering high-value oncology diagnostics that can help inform patient care decisions and improve outcomes.
Cellara is an early-stage Madison, Wisconsin-based biotechnology company developing workflow solutions to address critical issues.
Genome International Corporation (GIC) is a research-driven firm.
BioSentinel develops innovative tools and reagents for the study of botulinum neurotoxin (BoNT).
PPD is now part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and PPD are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We now offer a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product.
FluGen is a biopharmaceutical company specializing on the prevention and treatment of seasonal and pandemic influenza worldwide.
At Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems. Interactions with our customers, partners and vendors are central to everything we do, and we value those relationships. We seek out and build connections across the globe and in our local communities because creative problem solving requires a network of diverse ideas and viewpoints.
Cellscript is a pharmaceutical company
Fujifilm Cellular Dynamics, Inc. develops and manufactures biologically relevant human cells derived from induced pluripotent stem (iPS) cells. Our iCell® and donor-specific MyCell® Products are highly pure, highly reproducible, and available in industrial quantity to enable drug discovery, toxicity testing, stem cell banking, and cell therapy development.
Bellbrook Labs is a research and development company focusing on advancing drug discovery for human health therapies.
Atterx develops therapeutics to fight the growing epidemic of antibiotic resistant bacteria.
Proteovista is a microarray technology and applications for basic research and drug discovery company
Stem Pharm's synthetic biomaterials support the optimization of cell expansion
Work Your Passion. Live Your Purpose.